Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
32,418,922
-
Share change
-
+8,415,083
-
Total reported value
-
$651,281,538
-
Put/Call ratio
-
1738%
-
Price per share
-
$20.09
-
Number of holders
-
101
-
Value change
-
+$165,201,151
-
Number of buys
-
58
-
Number of sells
-
27
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q3 2023
As of 30 Sep 2023,
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,418,922 shares.
The largest 10 holders included
Paradigm Biocapital Advisors LP, Deep Track Capital, LP, First Light Asset Management, LLC, Jefferies Financial Group Inc., MORGAN STANLEY, Point72 Asset Management, L.P., BRAIDWELL LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, Candriam S.C.A., and Polar Capital Holdings Plc.
This page lists
101
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.